Stockscreener 앱 받기
0.6628
17.10%
0.0968
전일 마감가:
$0.566
열려 있는:
$0.533
하루 거래량:
1.24M
Relative Volume:
2.06
시가총액:
$1.75M
수익:
$574.20K
순이익/손실:
$-7.15M
주가수익비율:
-0.0417
EPS:
-15.8778
순현금흐름:
$-7.00M
1주 성능:
+13.36%
1개월 성능:
-19.50%
6개월 성능:
-73.49%
1년 성능:
-44.30%
1일 변동 폭
$0.533
$0.75
1주일 범위
$0.525
$0.75
52주 변동 폭
$0.5079
$5.89
애틀론 메디컬 Stock (AEMD) Company Profile
명칭
Aethlon Medical Inc
전화
619-941-0360
주소
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
0.6628 | 1.48M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
애틀론 메디컬 Stock (AEMD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | H.C. Wainwright | Neutral |
애틀론 메디컬 주식(AEMD)의 최신 뉴스
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Aethlon Medical, Inc. Revenue Breakdown – NASDAQ:AEMD - TradingView
AEMD|Aethlon Medical Inc|Price:0.585|Chg%:-0.016 - TradingKey
Aethlon Medical (AEMD) Dips 3.4% to $0.63 as Small-Cap Biotech Faces Persistent Selling PressureIntraday Profile - dars.gov.et
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Aethlon Medical at emerging growth conference: trial data and cash boost - Investing.com
AEMD: Hemopurifier shows early promise in oncology trials, with strong platform and financial position - TradingView
Aethlon Medical Reports Encouraging Hemopurifier Trial Results - t.co
Aethlon Medical (AEMD) Gains 2.39% as Stock Approaches $0.70 Resistance LevelSentiment Extreme - dars.gov.et
Aethlon Medical reports second cohort results from cancer study - Investing.com UK
Aethlon Medical (AEMD) Slides 5.4% as Pressure Mounts Near Key Support LevelEarnings Beat Stocks - dars.gov.et
Aethlon Medical advances Hemopurifier oncology study to third cohort - grafa.com
Aethlon Medical reports second cohort results from cancer study By Investing.com - Investing.com South Africa
Experimental cancer filter shows repeat immune and tumor-signal shifts in small Australian study - Stock Titan
Aethlon Medical Inc. (AEMD) Q2 2026 Earnings: Narrower Loss Exceeds ExpectationsPretax Income Report - DonanımHaber
Aethlon Medical Announces $4 Million At-the-Market Offering to Advance Cancer and Infectious Disease Therapies - Minichart
Aethlon Medical Announces July 2026 Financing Offering - TipRanks
Aethlon Medical (NASDAQ: AEMD) prices $4M follow-on at-the-market deal - Stock Titan
Aethlon Medical Raises ~$4.0 Million in Registered Offering Priced at $0.71; Maxim Group as Agent - TradingView
Aethlon Medical (AEMD) Q1 2025 earnings summary - Quartr
Aethlon Medical (AEMD) launches $0.71 unit offering registering 11.2M shares - Stock Titan
[EFFECT] AETHLON MEDICAL INC SEC Filing - Stock Titan
Aethlon Medical Inc. (AEMD) Slides 7.6% as Shares Approach Key Support LevelSell Signal Alerts - dars.gov.et
AEMDAethlon Medical Inc Latest SEC Filings - Finviz
Aethlon Medical prices $4M follow-on offering at $0.7101 - scanx.trade
Aethlon Medical prices $4M follow-on offering at $0.71 per share - Investing.com
Aethlon Medical Announces Pricing of $4.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules - TradingView
AEMD Q2 2026 Earnings: EPS Beat Highlights Cost Discipline Amid Pre-Revenue PhaseEarnings Preview - dars.gov.et
AEMD Q2 2026 Earnings: Narrower-than-Expected Loss Highlights Progress in Clinical PipelineSaaS Earnings Trends - DonanımHaber
Form 4 Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax - Stock Titan
Aethlon Medical (AEMD) director forfeits 2,182 shares to cover RSU tax withholding - Stock Titan
Director at Aethlon Medical (AEMD) forfeits 1,091 shares for tax withholding - Stock Titan
Form S-1/A AETHLON MEDICAL For: 1 July By Investing.com - Investing.com UK
Aethlon Medical (AEMD) updates S-1 with auditor consent, expenses - Stock Titan
Form S-1/A Aethlon Medical Inc For: 1 July By Investing.com - Investing.com Canada
Aethlon Medical (NASDAQ: AEMD) targets $4M unit offering of shares and warrants - Stock Titan
AEMD Q2 2021 Earnings Call - BigGo ファイナンス
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Aethlon Medical (AEMD) Slides 2.22% as Support Level Nears – Key Levels in FocusImbalance Zone - dars.gov.et
Aethlon Medical (AEMD) Reveals Key Research on Long COVID and Ex - GuruFocus
Aethlon Medical study links device to Long COVID markers - Investing.com UK
Aethlon Medical reports two-fold Long COVID signal - grafa.com
Breakthrough Long COVID Biomarker Identified by Aethlon Medical (Nasdaq: AEMD) Opens Door for Hemopurifier Treatment - Investorideas.com
Biotech's Rapid Response to the 2026 Ebola Outbreak: Vaccines, Antibodies, and Therapeutics Advance - Investorideas.com
Aethlon Medical study links device to Long COVID markers By Investing.com - Investing.com Canada
Aethlon study links Long COVID vesicles to Hemopurifier capture - Stock Titan
Price to sales forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Price to earnings forward of Aethlon Medical, Inc. – NASDAQ:AEMD - TradingView
Aethlon Medical tracks Ebola outbreak, readies Hemopurifier talks - Stock Titan
애틀론 메디컬 (AEMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.04%
11.95%
자본화:
|
볼륨(24시간):